At a glance
ClinicalIndex Comparison RecordEarly Ph 1Completed· 25 enrolled
Drug / intervention
Perflutren Lipid Microcpheres +2 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Interstitial Fluid Pressure Estimation in Breast Cancer Using 3D Subharmonic Signals From Contrast-Enhanced Ultrasound
In Brief
A Early Phase 1 clinical trial evaluating Ultrasonsgraphy, Perflutren Lipid Microcpheres, and 1 other intervention for Breast Carcinoma. Completed, enrolled 25 participants across 1 site.
Detailed Summary
This clinical trial studies the use of contrast-enhanced ultrasound (CEUS) in estimating tissue pressure in patients with breast cancer. Diagnostic procedures, such as CEUS, may help estimate tissue pressure noninvasively.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBreast Carcinoma
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI)
Timeline
Early Ph 1CompletedFinished
202120222023202420252026
Enrollment StartNov 2020
First PostedJan 2021
Primary CompletionJul 2023
TodayJul 2026
First PostedJan 25, 2021
Enrollment StartNov 24, 2020
Primary CompletionJul 11, 2023
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 5.4 years ago
Interventions
Ultrasonsgraphyprocedure
Undergo ultrasonography
Perflutren Lipid Microcpheresdrug
Given IV
Contrast - Enhanced Ultrasoundprocedure
Undergo CEUS